[CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT September 30, 2013 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]
[Ever-Glory Received a Warning Letter from NYSE Regulations Regarding Failure to Obtain its Audit Committee’s Prior Approve of Certain Related Party Transactions NANJING, China, October 7, 2013 /PRNewswire/ -- Ever-Glory International Group, Inc. (the "Company" or "Ever-Glory") (NYSE MKT: EVK), a leading apparel supply chain manager and retailer based in China, today announced that, on October 1, 2013, it received]
[Ever-Glory Received a Warning Letter from NYSE Regulations Regarding Failure to Obtain its Audit Committee’s Prior Approve of Certain Related Party Transactions NANJING, China, October 7, 2013 /PRNewswire/ -- Ever-Glory International Group, Inc. (the "Company" or "Ever-Glory") (NYSE MKT: EVK), a leading apparel supply chain manager and retailer based in China, today announced that, on October 1, 2013, it received]
[Ever-Glory Received a Warning Letter from NYSE Regulations Regarding Failure to Obtain its Auditmmittees Prior Approve of Certain Related Party Transactions NANJING, China, October 7, 2013 /PRNewswire/ -- Ever-Glory International, (the "Company" or "Ever-Glory") (NYSE MKT: EVK), a leading apparel supply chain manager and retailer based in China, today announced that, on October 1, 2013,]
[SINOCOKING COAL AND COKE CHEMICAL INDUSTRIES ANNOUNCES FISCAL 2013 YEAR-END FINANCIAL RESULTS PINGDINGSHAN, China – September 30, 2013 /PRNewswire-FirstCall/ - SinoCoking Coal and Coke Chemical Industries, Inc. (SCOK) (the "Company" or "SinoCoking"), Fiscal Year 2013 vs. 2012 · Total revenue decreased to $66.7 million, as compared to $78.9 million. · Gross margin decreased to 12.3%, as compared to 19.2%. ·] []
[SINOCOKING COAL AND COKE CHEMICAL INDUSTRIES ANNOUNCES FISCAL 2013 YEAR-END FINANCIAL RESULTS PINGDINGSHAN, China – September 30, 2013 /PRNewswire-FirstCall/ - SinoCoking Coal and Coke Chemical Industries, Inc. (SCOK) (the "Company" or "SinoCoking"), Fiscal Year 2013 vs. 2012 · Total revenue decreased to $66.7 million, as compared to $78.9 million. · Gross margin decreased to 12.3%, as compared to 19.2%. ·] []
[TPI Announces Fiscal Year 2013 Financial Results September 27, 2013 Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the fiscal year 2013. Fiscal Year 2013 Ended June 30, 2013 Financial Highlights: · Revenue was $67.5 million compared] [Tianyin Pharmaceutical Inc. Fiscal Year 2013 Annual Financial Results Conference Call September 27, 2013 Operator James Tong - Chief Financial Officer. Financial highlights of Fiscal year 2013 ended June 30, 2013: Revenue totaled $67.5 million compared with $69.6 million in fiscal year 2012, a decrease of 3% year-over-year. Operating income was $9.3 million, compared with $8.5 million in fiscal year] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT September 27, 2013 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]
[TPI Announces Fiscal Year 2013 Financial Results September 27, 2013 Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the fiscal year 2013. Fiscal Year 2013 Ended June 30, 2013 Financial Highlights: · Revenue was $67.5 million compared] [Tianyin Pharmaceutical Inc. Fiscal Year 2013 Annual Financial Results Conference Call September 27, 2013 Operator James Tong - Chief Financial Officer. Financial highlights of Fiscal year 2013 ended June 30, 2013: Revenue totaled $67.5 million compared with $69.6 million in fiscal year 2012, a decrease of 3% year-over-year. Operating income was $9.3 million, compared with $8.5 million in fiscal year] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT September 27, 2013 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]
